Goldman Sachs’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-166,025
| Closed | -$364K | – | 5243 |
|
|
2025
Q1 | $364K | Buy |
166,025
+122,073
| +278% | +$267K | ﹤0.01% | 4426 |
|
|
2024
Q4 | $143K | Buy |
+43,952
| New | +$143K | ﹤0.01% | 4717 |
|
|
2021
Q4 | – | Sell |
-4,649
| Closed | -$53K | – | 5594 |
|
|
2021
Q3 | $53K | Buy |
+4,649
| New | +$53K | ﹤0.01% | 5177 |
|